hotspot -WSS

hotspot

author：hotspot 2025-09-27 13:04:59 - browse：623

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Former Georgia lieutenant governor says he received grand jury subpoena

explore

knowledge

WSS

The painfully weak evidence on taking collagen to treat arthritis

FDA warns medical device makers about rise in fabricated data

Ohioans vote in high

Zapping the brain for stroke rehab: Pivotal clinical trial begins

As AI regulations shape up, health tech startups beg for clarity

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

entertainment

hotspot

focus

Medicare details structure of new drug price negotiation program

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Weight loss drugs aren’t covered by Obamacare. That may change

Walensky prepares to leave CDC — and Congress — behind

Biden praises World Series champion Astros for impact off the field during White House celebration

After affirmative action ruling, medical educators look to 'holistic review'

Researchers tackle phage therapy hurdles for wider adoption

New air purifier tech could be key to improving indoor air quality

WATCH: Why do our ears pop?

entertainment

Hospitals use virtual reality to design more inclusive rooms for kids

Lessons Learned: This is why you network to find that industry job you want

Former Georgia lieutenant governor says he received grand jury subpoena

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Judge rejects Trump's counterclaim against E. Jean Carroll

MD Anderson's Padmanee Sharma responds to research credit suit

explore

knowledge

knowledge

focus